£2.6M
Northstar Ventures and Par Equity co-led the investment round to support international expansion and US regulatory clearance.
MN
Manus Neurodynamica
Manus Neurodynamica develops diagnostic technology for neuromotor disorders.
£3.8MTotal raised
Manus Neurodynamica develops medical devices designed to aid in the diagnosis and monitoring of neuromotor disorders such as Parkinson disease.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Manus Neurodynamica's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
RZ
Rutger Zietsma
CEO
Investors
- £2.6MPEPar EquityLeadNENorth East Innovation FundFollow-onSIS VenturesFollow-on
Old College CapitalFollow-on
- £1.2M
Funding history
£1.2M
Northstar Ventures led the £1.2m round to support the commercial rollout of the medtech firm's diagnostic device.